Clinical Trials Browser

NCT06747169 2024-12-27

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Phase 2 Not yet recruiting

32 enrolled

Thoracic

Squamous Non-Small Cell Lung Cancer SqNSCLC

NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Phase 2 Unknown

30 enrolled

Thoracic

Locally Advanced Squamous Non-small Cell Lung Cancer

NCT05574998 2022-10-12

FTANLCNDG

Phase 2 Unknown

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Phase 2 Unknown

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05448781 2022-07-07

Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC

Phase 2 Unknown

38 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

Phase 2 Unknown

42 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Phase 2 Unknown

46 enrolled

Thoracic

Squamous Non-small Cell Lung Cancer

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

97 enrolled

Thoracic

Lung Neoplasms

NCT01733589 2017-07-14

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Phase 1/2 Completed

73 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

Phase 2 Unknown

150 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

134 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase 4 Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

10 enrolled

Thoracic

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

60 enrolled

Thoracic

Lung Neoplasms

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Phase 2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01347424 2013-12-09

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Phase 2 Unknown

40 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Neoplasms

NCT01218594 2012-10-17

DP-EN-RT

Phase 2 Unknown

50 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01211002 2010-09-29

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 4 Unknown

170 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01192230 2010-09-16

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

Phase 2 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Phase 2 Unknown

134 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01124253 2010-05-17

Dengshan

Phase 3 Completed

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01028729 2009-12-09

NSCLC

Phase 4 Unknown

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung